{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:49:41Z","timestamp":1765381781940,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.contraception.2011.12.011","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T08:29:08Z","timestamp":1332923348000},"page":"268-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The effects of 2 mg chlormadinone acetate\/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"86","author":[{"given":"Carolina Sales","family":"Vieira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wellington P.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana\u00edna Boldrini Fran\u00e7a","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Mafaldo","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana Maria","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Felipe Silva","family":"de S\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui Alberto","family":"Ferriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.12.011_bb0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2011.12.011_bb0010","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2011.12.011_bb0015","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2011.12.011_bb0020","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/AOG.0b013e3181bd12cb","article-title":"ACOG Practice Bulletin No. 108: polycystic ovary syndrome","volume":"114","author":"ACOG","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.12.011_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1742-1241.2008.01877.x","article-title":"Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome","volume":"63","author":"Soares","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.contraception.2011.12.011_bb0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11010-011-0793-6","article-title":"Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome","volume":"353","author":"Gomes","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.contraception.2011.12.011_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2011.12.011_bb0040","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","article-title":"Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis","volume":"340","author":"Celermajer","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2011.12.011_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2796.1999.0442f.x","article-title":"Cross-sectionally assessed carotid intima-media thickness relates to long-term risk of stroke, coronary heart disease and death as estimated by available risk functions","volume":"245","author":"Bots","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.contraception.2011.12.011_bb0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/01.CIR.0000105767.94169.E3","article-title":"Arterial stiffness, wave reflections, and the risk of coronary artery disease","volume":"109","author":"Weber","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2011.12.011_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"ESHRE\/ASRM","year":"2004","journal-title":"Hum Reprod"},{"year":"2010","series-title":"Medical eligibility criteria for contraceptive use","author":"WHO","key":"10.1016\/j.contraception.2011.12.011_bb0060"},{"key":"10.1016\/j.contraception.2011.12.011_bb0065","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.107.185649","article-title":"Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association","volume":"116","author":"Haskell","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2011.12.011_bb0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.contraception.2011.12.011_bb0075","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.contraception.2011.12.011_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.contraception.2008.07.024","article-title":"Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women","volume":"79","author":"Lizarelli","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.011_bb0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7863\/jum.2008.27.5.693","article-title":"Brachial artery pulsatility index change 1 minute after 5-minute forearm compression: comparison with flow-mediated dilatation","volume":"27","author":"Martins","year":"2008","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.contraception.2011.12.011_bb0090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.maturitas.2008.09.019","article-title":"Sonographic evaluation of endothelial function in letrozole and tamoxifen users","volume":"61","author":"Nastri","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2011.12.011_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0100-72032009000300002","article-title":"Cardiovascular risk markers in polycystic ovary syndrome in women with and without insulin resistance","volume":"31","author":"Martins","year":"2009","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.contraception.2011.12.011_bb0100","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2141.2010.08206.x","article-title":"Risk factors for venous thrombosis \u2014 current understanding from an epidemiological point of view","volume":"149","author":"Lijfering","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2011.12.011_bb0105","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2011.12.011_bb0110","doi-asserted-by":"crossref","first-page":"529.e1","DOI":"10.1016\/j.ajog.2008.04.013","article-title":"Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population","volume":"199","author":"Morin-Papunen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.12.011_bb0115","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2007.01.027","article-title":"Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.011_bb0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.jhh.1001841","article-title":"Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension","volume":"19","author":"Lubianca","year":"2005","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.contraception.2011.12.011_bb0125","first-page":"CD006133","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus","author":"Lopez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2011.12.011_bb0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","article-title":"The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients","volume":"20","author":"Cibula","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.12.011_bb0135","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.12.011_bb0140","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/00004872-200018110-00001","volume":"18","author":"Safar","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.contraception.2011.12.011_bb0145","first-page":"91","article-title":"Flow-mediated dilatation in polycystic ovary syndrome women","volume":"e23","author":"Martins","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.12.011_bb0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc06-0618","article-title":"Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome","volume":"30","author":"Meyer","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.contraception.2011.12.011_bb0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-10-0709","article-title":"Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome","volume":"164","author":"Studen","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.contraception.2011.12.011_bb0160","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.fertnstert.2009.10.016","article-title":"Comparison of effects of 3 mg drospirenone plus 20 mcg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"94","author":"Fruzzetti","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.12.011_bb0165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.contraception.2010.04.002","article-title":"Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome","volume":"82","author":"De Leo","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.011_bb0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/13697130500345109","article-title":"Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article","volume":"8","author":"Lakoski","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2011.12.011_bb0175","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.12.011_bb0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"J Endocrinol Invest"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411007438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411007438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:44:15Z","timestamp":1761432255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411007438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0010782411007438"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.12.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of 2 mg chlormadinone acetate\/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2011.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}